WEST PHARMACEUTICAL SERVICES

Explore how West Pharmaceutical Services’ 19% CAGR fuels pharma manufacturing growth while Aur’s Minerals boosts governance and capital for mining success.

West Pharmaceutical Services will release Q3‑2026 results before the market opens on Oct. 29, offering investors early insight into its injectable drug‑delivery growth and strategy.

Discover how West Pharmaceutical’s SelfDose® platform will reshape injectable drug delivery at CPHI 2026, boosting patient adherence, reducing costs, and unlocking new market growth.

West Pharmaceutical Services officer update: minor share change, phantom‑stock plan, no dilution impact, but financial, supply‑chain and tech‑investment challenges outlined.